Sort   by:  
 Page size 
UnknownMatching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor.
Not available
S-EPMC11052850 | biostudies-literature
GenomicsE2F7 represses a transcriptional network of oscillating cell cycle genes to control S-phase progression.
E2F transcription factors are known to be important for timely activation of G1/S and G2/M genes required for cell cycle progression, but transcriptional mechanisms for deactivation of cell cycle regulated genes are unknown. Here, we show that E2F7 is highly expressed during mid to late S-phase, occ...
ORGANISM(S): Homo sapiens 
2012-01-04 | E-GEOD-32673 | biostudies-arrayexpress
UnknownPirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study.
Not available
S-EPMC12686794 | biostudies-literature
UnknownInterchangeability of biosimilars: A study of expert views and visions regarding the science and substitution.
Not available
S-EPMC8751983 | biostudies-literature
UnknownmTOR signaling in liver regeneration: Rapamycin combined with growth factor treatment.
Not available
S-EPMC3832859 | biostudies-literature
UnknownA de novo CTNNB1 Novel Splice Variant in an Adult Female with Severe Intellectual Disability.
Not available
S-EPMC7548236 | biostudies-literature
TranscriptomicsMouse heart tissue: wild-type vs. aMHC-Calcineurin transgenic (CnTg)
Cardiac profiling of miR expression levels in a transgenic mouse model of heart failure (MHC-CnA) to identify miRs that are co-regulated with the development of calcineurin-induced heart failure. Two-condition experiment: WT vs CnTg. Biological replicates: one array was performed on 3 pooled samples...
ORGANISM(S): Mus musculus 
2011-11-02 | E-GEOD-25006 | biostudies-arrayexpress
UnknownConcomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition.
Not available
S-EPMC8854729 | biostudies-literature
UnknownPirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Not available
S-EPMC11758240 | biostudies-literature
UnknownGuidance for pediatric use in prescription information for novel medicinal products in the EU and the US.
Not available
S-EPMC8979467 | biostudies-literature
Sort   by:  
 Page size